OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value

$1.68+0.01 (+0.60%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

OPKO Health gross margin

Gross margin is gross profit as a percentage of revenue.

OPKO Health's gross margin for the twelve months ending Sep 30, 2026 was 56.6%. For fiscal 2025 it was 33.9%, against 30.6% the year before. The highest annual figure on record is 95.8% in fiscal 2016.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	33.9%	+3.3
FY2024	Dec 31, 2024	30.6%	−6.2
FY2023	Dec 31, 2023	36.8%	+8.1
FY2022	Dec 31, 2022	28.7%	−65.0
FY2017	Dec 31, 2017	93.7%	−2.1
FY2016	Dec 31, 2016	95.8%	+4.3
FY2015	Dec 31, 2015	91.5%	+1.8
FY2014	Dec 31, 2014	89.7%	+0.5
FY2013	Dec 31, 2013	89.2%	+48.5
FY2012	Dec 31, 2012	40.7%	+2.4
FY2011	Dec 31, 2011	38.4%	−14.3
FY2010	Dec 31, 2010	52.6%	+17.7
FY2009	Dec 31, 2009	34.9%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	64.3%	+2.2
Q2 FY2026	Jun 30, 2026	48.9%	+17.4
Q1 FY2026	Mar 31, 2026	36.8%	+8.4
Q4 FY2025	Dec 31, 2025	78.1%	+32.0
Q3 FY2025	Sep 30, 2025	62.1%	+39.0
Q2 FY2025	Jun 30, 2025	31.5%	+3.2
Q1 FY2025	Mar 31, 2025	28.4%	+4.2
Q4 FY2024	Dec 31, 2024	46.1%	−48.2
Q3 FY2024	Sep 30, 2024	23.1%	−66.5
Q2 FY2024	Jun 30, 2024	28.4%	−65.1
Q1 FY2024	Mar 31, 2024	24.2%	−71.2
Q1 FY2018	Mar 31, 2018	94.3%	−0.2
Q4 FY2017	Dec 31, 2017	89.6%	−5.9
Q3 FY2017	Sep 30, 2017	93.5%	–
Q2 FY2017	Jun 30, 2017	95.4%	–
Q1 FY2017	Mar 31, 2017	94.4%	–
Q4 FY2016	Dec 31, 2016	95.5%	–